Skip to ContentSkip to Navigation
How to find us F.A. Eggink, MSc

Publications

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study

A transcriptionally distinct CXCL13+CD103+CD8+ T-cell population is associated with B-cell recruitment and neoantigen load in human cancer

Ovarian cancer

Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade

Improving quality of care for patients with ovarian and endometrial cancer

COMPLIANCE TO ADJUVANT TREATMENT GUIDELINES IN ENDOMETRIAL CANCER: ROOM FOR IMPROVEMENT IN HIGH RISK PATIENTS

Compliance with adjuvant treatment guidelines in endometrial cancer: Room for improvement in high risk patients

Corrigendum to: Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification (vol 78, pg 82, 2017)

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Read more